A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility,Blood

当前位置： X-MOL 学术 › Blood › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility
Blood ( IF 20.3 ) Pub Date : 2017-11-16 , DOI: 10.1182/blood-2017-08-800565
Erin C Peckham-Gregory _{1,

2} , Rikhia Chakraborty _{1,

2} , Michael E Scheurer _{1,

2} , John W Belmont _{3,

4} , Harshal Abhyankar ₁ , Amel G Sengal ₁ , Brooks P Scull ₁ , Olive Eckstein ₁ , Daniel J Zinn ₁ , Louisa Mayer _{1,

2} , Albert Shih ₁ , Miriam Merad ₅ , D Williams Parsons _{1,

2,

3} , Kenneth L McClain _{1,

2} , Philip J Lupo _{1,

2} , Carl E Allen _{1,

2}

Affiliation

To the editor: Langerhans cell histiocytosis (LCH) is a hematologic disorder that presents with a wide spectrum of symptoms, ranging from focal lesions to potentially lethal multiorgan disease, affecting 4 to 8 per million children per year[1][1] and 1 to 2 per million adults per year.[2][2]

中文翻译：